New Blood Test May Detect Tinnitus, UConn Studies Find

Inner-Ear Protein Shows Promise as Diagnostic Tool

Researchers at the University of Connecticut have linked elevated blood levels of an inner-ear protein called prestin to tinnitus in two clinical studies, offering early evidence that the protein could eventually serve as a biological marker for the notoriously subjective hearing disorder.

Prestin plays an essential role in outer hair cells inside the cochlea, helping those specialized cells amplify sound vibrations and fine-tune hearing sensitivity. UConn researcher Dr. Kourosh Parham theorizes that prestin can leak into circulation under certain conditions, providing clues about what is happening inside the inner ear.

Two Studies Show Elevated Protein Levels in Tinnitus Patients

In the first study, published in Otology & Neurotology, researchers measured serum prestin in 89 people, including 49 with chronic tinnitus and 40 control participants. Prestin concentrations were significantly higher among participants with tinnitus.

A second study published in Otolaryngology–Head & Neck Surgery examined 82 people, evenly divided between patients with chronic bilateral tinnitus and controls. Researchers measured prestin alongside three other inner-ear proteins and again found significantly elevated levels among the tinnitus group, even after accounting for factors including age, hearing thresholds and daily noise exposure. The other proteins did not distinguish participants with tinnitus from those without it.

Electronic Music Community Faces Widespread Tinnitus Risk

The condition, commonly experienced as ringing, buzzing or other phantom sounds without an external source, is generally assessed through patients' descriptions of what they hear and how severely it affects sleep, concentration and quality of life. There is currently no cure, though treatments can help patients manage its effects.

A 2025 survey of 2,000 people ages 18 to 28 found that four out of five nightclub attendees said they had experienced temporary tinnitus after a night out. 58% reported hearing loss, tinnitus or both after attending clubs, concerts or festivals.

Electronic music enthusiasts appear particularly aware of the risk. A separate study of more than 2,000 live music attendees found that EDM fans were more likely to protect themselves, with roughly 70% of EDM attendees reporting using hearing protection compared to about 59% of other concertgoers. Meanwhile, the use of high-fidelity earplugs was also substantially more common among EDM fans.

That awareness has increasingly reached the artists behind the decks. Superstars like Martin Garrix and Alesso have shed light on their experiences with tinnitus impacting their personal and professional lives.

Long Road to Clinical Application

Parham believes the findings provide proof of concept for using prestin as a tinnitus biomarker and hopes larger studies could ultimately help researchers identify therapeutic targets. But there is an important caveat: neither study was large enough to establish prestin as a clinical diagnostic test. The researchers themselves are calling for replication in larger populations, and a recent systematic review of tinnitus biomarker research concluded that no single objective measure is yet ready to independently diagnose the condition.

For a music industry increasingly confronting the consequences of lifelong exposure to loud sound, the research offers something tinnitus researchers have long lacked: an objective biological clue to a condition defined almost entirely by what a patient can hear but a doctor cannot.